Clinical Trial Update: A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement [Phase 2]

View source ↗

Summary

Phase 2 trial of LY2495655 in older adults undergoing elective total hip replacement for muscular atrophy has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscular Atrophy

Drugs mentioned

• LY2495655

Snippet

Sponsor: Eli Lilly and Company | Conditions: Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2018-06-06